News
Recent news about Panacea Capital and select portfolio companies
March 10, 2026
Meet HiRO at PHUSE US Connect 2026 in Austin
We’re excited to join PHUSE US Connect 2026, taking place March 22–26, 2026 in Austin,…
March 10, 2026
Meet HiRO at PHUSE US Connect 2026 in Austin
We’re excited to join PHUSE US Connect 2026, taking place March 22–26, 2026 in Austin,…
March 10, 2026
Base to Base Biotech podcast with Sean A. MacDonald, CEO at Kainova Therapeutics – GPCRs and beating neurodegenerative diseases
March 10, 2026
Base to Base Biotech podcast with Sean A. MacDonald, CEO at Kainova Therapeutics – GPCRs and beating neurodegenerative diseases
March 10, 2026
Kainova Therapeutics Announces Positive Phase I Results for DT-9081, an Oral EP4 Receptor Antagonist, in Advanced Solid Tumors
March 10, 2026
Kainova Therapeutics Announces Positive Phase I Results for DT-9081, an Oral EP4 Receptor Antagonist, in Advanced Solid Tumors
March 6, 2026
Labiotech Beyond Biotech podcast with Sean A. MacDonald, CEO of Kainova Therapeutics – Reversing tumor immunosuppression with next-gen GPCR modulation
March 6, 2026
Labiotech Beyond Biotech podcast with Sean A. MacDonald, CEO of Kainova Therapeutics – Reversing tumor immunosuppression with next-gen GPCR modulation
March 3, 2026
HiRO Leads Cross‑Border Dialogue at JPM, Offering Insights for Biotechs Seeking Asian Investment
SOMERSET, N.J., March 3, 2026 -- Harvest Integrated Research Organization (HiRO), a global contract research…
March 3, 2026
HiRO Leads Cross‑Border Dialogue at JPM, Offering Insights for Biotechs Seeking Asian Investment
SOMERSET, N.J., March 3, 2026 -- Harvest Integrated Research Organization (HiRO), a global contract research…